Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jian-Ge Qiu

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Oncotarget|May 13, 2015
Cyclin-dependent kinase inhibitor dinaciclib potently synergizes with cisplatin in preclinical models of ovarian cancerXiu-Xiu Chen, Feng-Feng Xie, Xiu-Jie Zhu, et al.
Oncotarget|October 9, 2015
Synergistic anticancer effects of triptolide and celastrol, two main compounds from thunder god vineQi-Wei Jiang, Ke-Jun Cheng, Xiao-Long Mei, et al.
Cancer Letters|November 20, 2016
Synergistic antitumor activity of regorafenib and lapatinib in preclinical models of human colorectal cancerWen-Ji Zhang, Yong Li, Meng-Ning Wei, et al.
Journal of Hematology & Oncology|January 27, 2017
MiR-194 functions as a tumor suppressor in laryngeal squamous cell carcinoma by targeting Wee1Pei Li, Yang Yang, Hui Liu, et al.
American Journal of Translational Research|May 5, 2017
Crizotinib synergizes with cisplatin in preclinical models of ovarian cancerXiao-Xiu Huang, Feng-Feng Xie, Li-Jiao Hou, et al.
Molecular Medicine (Cambridge, Mass.)|February 13, 2021
Discovery of vanoxerine dihydrochloride as a CDK2/4/6 triple-inhibitor for the treatment of human hepatocellular carcinomaYing Zhu, Kun-Bin Ke, Zhong-Kun Xia, et al.
Frontiers in Pharmacology|August 2, 2021
Discovery of a New CDK4/6 and PI3K/AKT Multiple Kinase Inhibitor Aminoquinol for the Treatment of Hepatocellular CarcinomaZhong-Kun Xia, Wei Wang, Jian-Ge Qiu, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Oncotarget|May 13, 2015
Cyclin-dependent kinase inhibitor dinaciclib potently synergizes with cisplatin in preclinical models of ovarian cancerXiu-Xiu Chen, Feng-Feng Xie, Xiu-Jie Zhu, et al.
Oncotarget|October 9, 2015
Synergistic anticancer effects of triptolide and celastrol, two main compounds from thunder god vineQi-Wei Jiang, Ke-Jun Cheng, Xiao-Long Mei, et al.
Cancer Letters|November 20, 2016
Synergistic antitumor activity of regorafenib and lapatinib in preclinical models of human colorectal cancerWen-Ji Zhang, Yong Li, Meng-Ning Wei, et al.
Journal of Hematology & Oncology|January 27, 2017
MiR-194 functions as a tumor suppressor in laryngeal squamous cell carcinoma by targeting Wee1Pei Li, Yang Yang, Hui Liu, et al.
American Journal of Translational Research|May 5, 2017
Crizotinib synergizes with cisplatin in preclinical models of ovarian cancerXiao-Xiu Huang, Feng-Feng Xie, Li-Jiao Hou, et al.
Molecular Medicine (Cambridge, Mass.)|February 13, 2021
Discovery of vanoxerine dihydrochloride as a CDK2/4/6 triple-inhibitor for the treatment of human hepatocellular carcinomaYing Zhu, Kun-Bin Ke, Zhong-Kun Xia, et al.
Frontiers in Pharmacology|August 2, 2021
Discovery of a New CDK4/6 and PI3K/AKT Multiple Kinase Inhibitor Aminoquinol for the Treatment of Hepatocellular CarcinomaZhong-Kun Xia, Wei Wang, Jian-Ge Qiu, et al.
Pageof 7